应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01513 丽珠医药
已收盘 01-12 16:08:30
29.920
-0.100
-0.33%
最高
30.020
最低
29.500
成交量
52.91万
今开
30.000
昨收
30.020
日振幅
1.73%
总市值
265.69亿
流通市值
89.76亿
总股本
8.88亿
成交额
1,575万
换手率
0.18%
流通股本
3.00亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每日卖空追踪 | 丽珠医药 01月12日卖空量成交5800股,卖空比例为1.12%
市场透视 · 16:30
每日卖空追踪 | 丽珠医药 01月12日卖空量成交5800股,卖空比例为1.12%
每日卖空追踪 | 丽珠医药 01月08日卖空量成交1.72万股,卖空比例为3.31%
市场透视 · 01-08
每日卖空追踪 | 丽珠医药 01月08日卖空量成交1.72万股,卖空比例为3.31%
丽珠医药(01513):莱康奇塔单抗注射液被纳入优先审评审批程序
智通财经 · 01-07
丽珠医药(01513):莱康奇塔单抗注射液被纳入优先审评审批程序
每日卖空追踪 | 丽珠医药 01月07日卖空量成交2.42万股,卖空比例为1.67%
市场透视 · 01-07
每日卖空追踪 | 丽珠医药 01月07日卖空量成交2.42万股,卖空比例为1.67%
丽珠医药01月07日获主力加仓159.3万元
市场透视 · 01-07
丽珠医药01月07日获主力加仓159.3万元
丽珠医药01月06日获主力加仓504.9万元
市场透视 · 01-06
丽珠医药01月06日获主力加仓504.9万元
丽珠医药(01513)12月31日注销1619.33万股已回购A股
智通财经 · 01-05
丽珠医药(01513)12月31日注销1619.33万股已回购A股
突发!丽珠医药旗下宠物药公司控股权易主
药事纵横 · 01-01
突发!丽珠医药旗下宠物药公司控股权易主
每日卖空追踪 | 丽珠医药 12月31日卖空量成交1.17万股,卖空比例为3.55%
市场透视 · 2025-12-31
每日卖空追踪 | 丽珠医药 12月31日卖空量成交1.17万股,卖空比例为3.55%
丽珠医药(01513):健康元拟将毛孩子49%股权转让给心有毛孩
智通财经 · 2025-12-30
丽珠医药(01513):健康元拟将毛孩子49%股权转让给心有毛孩
丽珠医药(01513)聘任夏雨为公司证券事务代表
智通财经 · 2025-12-30
丽珠医药(01513)聘任夏雨为公司证券事务代表
每日卖空追踪 | 丽珠医药 12月30日卖空量成交8500股,卖空比例为0.79%
市场透视 · 2025-12-30
每日卖空追踪 | 丽珠医药 12月30日卖空量成交8500股,卖空比例为0.79%
丽珠集团:积极布局下一代产品线,多业务发展态势向好
财中社 · 2025-12-26
丽珠集团:积极布局下一代产品线,多业务发展态势向好
瞩目,丽珠医药又一重磅1类新药申报上市
北京药研汇 · 2025-12-25
瞩目,丽珠医药又一重磅1类新药申报上市
每日卖空追踪 | 丽珠医药 12月24日卖空量成交4700股,卖空比例为4.51%
市场透视 · 2025-12-24
每日卖空追踪 | 丽珠医药 12月24日卖空量成交4700股,卖空比例为4.51%
丽珠医药(01513)莱康奇塔单抗申报上市 用于治疗斑块状银屑病
智通财经 · 2025-12-24
丽珠医药(01513)莱康奇塔单抗申报上市 用于治疗斑块状银屑病
国产首款:丽珠医药IL-17A/F抗体申报上市
医药笔记 · 2025-12-24
国产首款:丽珠医药IL-17A/F抗体申报上市
每日卖空追踪 | 丽珠医药 12月22日卖空量成交1.63万股,卖空比例为5.22%
市场透视 · 2025-12-22
每日卖空追踪 | 丽珠医药 12月22日卖空量成交1.63万股,卖空比例为5.22%
丽珠医药12月22日遭主力抛售27.0万元
市场透视 · 2025-12-22
丽珠医药12月22日遭主力抛售27.0万元
丽珠医药(01513):NS-041 片新增治疗抑郁症适应症获得药物临床试验批准通知书
智通财经 · 2025-12-21
丽珠医药(01513):NS-041 片新增治疗抑郁症适应症获得药物临床试验批准通知书
加载更多
公司概况
公司名称:
丽珠医药
所属市场:
SEHK
上市日期:
--
主营业务:
丽珠医药集团股份有限公司是一家主要从事医药产品的研发、生产及销售业务的中国公司。该公司的主要业务包括化学制剂、生物制品、原料药及中间体、中药制剂、诊断试剂和设备,以及商业发展和职能管理。该公司的主要产品品牌包括“壹丽安”(艾普拉唑肠溶片及注射用艾普拉唑钠)、“丽珠得乐”(枸橼酸铋钾)系列产品、“丽倍乐”(雷贝拉唑钠肠溶胶囊)、“维三联”(枸橼酸铋钾片/替硝唑片/克拉霉素片)、“贝依”(注射用醋酸亮丙瑞林微球)、“丽申宝”(注射用尿促卵泡素)、“乐宝得”(注射用尿促性素)、“丽福康”(注射用伏立康唑)等。该公司主要在中国国内和海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01513","market":"HK","secType":"STK","nameCN":"丽珠医药","latestPrice":29.92,"timestamp":1768205310005,"preClose":30.02,"halted":0,"volume":529100,"delay":0,"floatShares":300000000,"shares":888000000,"eps":2.5059801632127994,"marketStatus":"已收盘","change":-0.1,"latestTime":"01-12 16:08:30","open":30,"high":30.02,"low":29.5,"amount":15745585,"amplitude":0.017322,"askPrice":29.92,"askSize":1200,"bidPrice":29.78,"bidSize":2200,"shortable":3,"etf":0,"ttmEps":2.668434156616925,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768267800000},"marketStatusCode":5,"adr":0,"listingDate":1389801600000,"exchange":"SEHK","adjPreClose":30.02,"dividendRate":0.040985,"openAndCloseTimeList":[[1768181400000,1768190400000],[1768194000000,1768204800000]],"volumeRatio":0.677293,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"000513","market":"SZ","secType":"STK","nameCN":"丽珠集团","latestPrice":36.31,"timestamp":1768201200000,"preClose":36.58,"halted":0,"volume":8543200,"delay":0,"premium":"-26.36"}},"requestUrl":"/m/hq/s/01513","defaultTab":"news","newsList":[{"id":"2602516800","title":"每日卖空追踪 | 丽珠医药 01月12日卖空量成交5800股,卖空比例为1.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602516800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602516800?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:30","pubTimestamp":1768206620,"startTime":"0","endTime":"0","summary":"丽珠医药北京时间01月12日,跌0.33%,卖空量成交5800股,较上一交易日减少73.02%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112164705a4b9d1e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112164705a4b9d1e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01513"],"gpt_icon":0},{"id":"2602054396","title":"每日卖空追踪 | 丽珠医药 01月08日卖空量成交1.72万股,卖空比例为3.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602054396","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602054396?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:30","pubTimestamp":1767861023,"startTime":"0","endTime":"0","summary":"丽珠医药北京时间01月08日,跌1.64%,卖空量成交1.72万股,较上一交易日减少78.01%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164518a7023b10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108164518a7023b10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01513"],"gpt_icon":0},{"id":"2601874834","title":"丽珠医药(01513):莱康奇塔单抗注射液被纳入优先审评审批程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2601874834","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601874834?lang=zh_cn&edition=full","pubTime":"2026-01-07 18:37","pubTimestamp":1767782269,"startTime":"0","endTime":"0","summary":"智通财经APP讯,丽珠医药(01513)发布公告,丽珠医药集团股份有限公司Livzon Pharmaceutical Group Inc.*(本公司)控股子公司珠海市丽珠单抗生物技术有限公司(丽珠单抗)与北京鑫康合生物医药科技有限公司联合开发的产品莱康奇塔单抗注射液(本品)于2025年12月26日被国家药品监督管理局药品审评中心纳入拟优先审评品种公示名单;现公示期满后,根据国家药品监督管理局药品审评中心网站信息公开显示,本品已纳入优先审评品种名单,正式进入药品上市许可优先审评审批程序。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389949.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01513"],"gpt_icon":0},{"id":"2601386396","title":"每日卖空追踪 | 丽珠医药 01月07日卖空量成交2.42万股,卖空比例为1.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601386396","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601386396?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:30","pubTimestamp":1767774622,"startTime":"0","endTime":"0","summary":"丽珠医药北京时间01月07日,涨1.8%,卖空量成交2.42万股,较上一交易日减少58.77%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163306a6fddcf6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163306a6fddcf6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01513"],"gpt_icon":0},{"id":"2601238635","title":"丽珠医药01月07日获主力加仓159.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601238635","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601238635?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:16","pubTimestamp":1767773764,"startTime":"0","endTime":"0","summary":"01月07日, 丽珠医药股价涨1.80%,报收30.50元,成交金额4419.1万元,换手率0.48%,振幅3.60%,量比2.21。丽珠医药今日主力资金净流入159.3万元,连续3日净流入,上一交易日主力净流入504.9万元。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为40.00%,平均涨幅为1.64%。该股近5个交易日上涨7.91%,主力资金累计净流入182.9万元;近20日主力资金累计净流出237.4万元,其中净流出天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107162339a4a6d8bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107162339a4a6d8bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01513","BK1191"],"gpt_icon":0},{"id":"2601606168","title":"丽珠医药01月06日获主力加仓504.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601606168","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601606168?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:15","pubTimestamp":1767687325,"startTime":"0","endTime":"0","summary":"01月06日, 丽珠医药股价涨2.39%,报收29.96元,成交金额2759.0万元,换手率0.31%,振幅3.42%,量比1.51。丽珠医药今日主力资金净流入504.9万元,上一交易日主力净流入51.3万元。该股近5个交易日上涨5.54%,主力资金累计净流入116.1万元,其中1个交易日为股价下跌时净流入;近20日主力资金累计净流出407.5万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106161715a6f97030&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106161715a6f97030&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01513","BK1191"],"gpt_icon":0},{"id":"2601830518","title":"丽珠医药(01513)12月31日注销1619.33万股已回购A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601830518","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601830518?lang=zh_cn&edition=full","pubTime":"2026-01-05 19:33","pubTimestamp":1767612787,"startTime":"0","endTime":"0","summary":"智通财经APP讯,丽珠医药(01513)发布公告,于2025年12月31日注销1619.33万股已回购A股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388803.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01513","BK1191","159982","399300"],"gpt_icon":0},{"id":"2600703930","title":"突发!丽珠医药旗下宠物药公司控股权易主","url":"https://stock-news.laohu8.com/highlight/detail?id=2600703930","media":"药事纵横","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600703930?lang=zh_cn&edition=full","pubTime":"2026-01-01 08:06","pubTimestamp":1767226014,"startTime":"0","endTime":"0","summary":"12月30日,丽珠医药与健康元同步发布正式公告,披露了其参股的宠物药研发公司——“毛孩子动物保健(广东)有限公司”完成了一次关键的股权重组。丽珠医药旗下宠物药研发公司“毛孩子”获得关联方“心有毛孩”增资1500万元人民币,股权结构相应变更。由此,毛孩子将不再纳入丽珠医药的合并财务报表范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101094525a6e76723&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260101094525a6e76723&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01513"],"gpt_icon":0},{"id":"2595772017","title":"每日卖空追踪 | 丽珠医药 12月31日卖空量成交1.17万股,卖空比例为3.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595772017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595772017?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:30","pubTimestamp":1767169822,"startTime":"0","endTime":"0","summary":"丽珠医药北京时间12月31日,涨1.57%,卖空量成交1.17万股,较上一交易日减少66.57%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231163302a48dc5e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231163302a48dc5e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01513","BK1191"],"gpt_icon":0},{"id":"2595679943","title":"丽珠医药(01513):健康元拟将毛孩子49%股权转让给心有毛孩","url":"https://stock-news.laohu8.com/highlight/detail?id=2595679943","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595679943?lang=zh_cn&edition=full","pubTime":"2025-12-30 18:58","pubTimestamp":1767092313,"startTime":"0","endTime":"0","summary":"智通财经APP讯,丽珠医药 发布公告,于2025年12月30日,本公司与健康元、心有毛孩及毛孩子订立增资认购及股权转让协议,心有毛孩同意对毛孩子以现金方式增资认缴人民币1500万元,同时,健康元同意将所持有毛孩子49%的股权转让给心有毛孩。本次交易完成后,心有毛孩将持有毛孩子52.56%的股权,本公司持有的毛孩子股权将从51.00%摊薄至47.44%,健康元将不再持有毛孩子股权,毛孩子不再纳入本公司合并报表范围内。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387239.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK0188","BK0239","BK1191","01513","BK0028","600380","BK0077","BK0114"],"gpt_icon":0},{"id":"2595799546","title":"丽珠医药(01513)聘任夏雨为公司证券事务代表","url":"https://stock-news.laohu8.com/highlight/detail?id=2595799546","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595799546?lang=zh_cn&edition=full","pubTime":"2025-12-30 18:56","pubTimestamp":1767092194,"startTime":"0","endTime":"0","summary":"智通财经APP讯,丽珠医药(01513)发布公告,丽珠医药集团股份有限公司(以下简称“公司”)董事会于近日收到公司证券事务代表李笑雨女士提交的辞呈。因个人原因,李笑雨女士辞去公司证券事务代表职务,辞呈自送达公司董事会之日起生效,李笑雨女士辞职后将不再担任公司任何职务。公司于2025年12月30日召开了第十一届董事会第三十一次会议,审议通过了《关于聘任公司证券事务代表的议案》,同意聘任夏雨女士为公司证券事务代表,协助董事会秘书履行相关职责。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","161027","01513"],"gpt_icon":0},{"id":"2595797127","title":"每日卖空追踪 | 丽珠医药 12月30日卖空量成交8500股,卖空比例为0.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595797127","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595797127?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:30","pubTimestamp":1767083421,"startTime":"0","endTime":"0","summary":"丽珠医药北京时间12月30日,跌1.47%,卖空量成交8500股,较上一交易日减少79.91%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163303a6e07bed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163303a6e07bed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01513","BK1191"],"gpt_icon":0},{"id":"2594923297","title":"丽珠集团:积极布局下一代产品线,多业务发展态势向好","url":"https://stock-news.laohu8.com/highlight/detail?id=2594923297","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594923297?lang=zh_cn&edition=full","pubTime":"2025-12-26 09:04","pubTimestamp":1766711094,"startTime":"0","endTime":"0","summary":"丽珠集团发布公告,丽珠集团于2025年12月25日举行了投资者关系活动,参与的投资机构共计13家。公司还提到,针对未来可能的集采风险,已布局下一代消化道产品P-CAB——JP-1366,预计其片剂将于2028年开始销售。此外,公司在中药治疗精神性疾病方面也在积极布局,研发1.1类中药产品。丽珠生物的管线中,莱康奇塔单抗已向药监局递交上市申请,预计将参加2027年国家医保谈判。2025年前三季度,丽珠集团实现收入91.16亿元,归母净利润17.54亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226090527a6d0607f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251226090527a6d0607f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01513","BK1191"],"gpt_icon":0},{"id":"2594232630","title":"瞩目,丽珠医药又一重磅1类新药申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2594232630","media":"北京药研汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594232630?lang=zh_cn&edition=full","pubTime":"2025-12-25 08:00","pubTimestamp":1766620856,"startTime":"0","endTime":"0","summary":"2025年12月24日,据中国国家药品审评中心官网最新公示,珠海市丽珠单抗生物技术有限公司按治疗用生物制品1类申报的新药莱康奇塔单抗注射液上市申请获受理。据丽珠集团新闻稿,莱康奇塔单抗注射液为丽珠医药开发的 IL-17A/F 双靶点抑制剂,本次申报的适应症可能为中度至重度慢性斑块状银屑病。2025年7月,丽珠医药宣布,LZM012用于中重度斑块型银屑病治疗的 Ⅲ 期临床试验成功达到主要研究终点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225081623a6cc1979&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225081623a6cc1979&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01513"],"gpt_icon":0},{"id":"2594409610","title":"每日卖空追踪 | 丽珠医药 12月24日卖空量成交4700股,卖空比例为4.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594409610","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594409610?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:30","pubTimestamp":1766565020,"startTime":"0","endTime":"0","summary":"丽珠医药北京时间12月24日,跌0.48%,卖空量成交4700股,较上一交易日减少74.18%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163257a6c9835e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224163257a6c9835e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01513"],"gpt_icon":0},{"id":"2593421604","title":"丽珠医药(01513)莱康奇塔单抗申报上市 用于治疗斑块状银屑病","url":"https://stock-news.laohu8.com/highlight/detail?id=2593421604","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593421604?lang=zh_cn&edition=full","pubTime":"2025-12-24 13:58","pubTimestamp":1766555914,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,12月24日,CDE网站显示,丽珠医药/鑫康合生物合作开发的莱康奇塔单抗申报上市,用于治疗斑块状银屑病。今年7月,丽珠医药宣布莱康奇塔单抗对比司库奇尤单抗治疗伴或不伴银屑病关节炎的中度至重度斑块状银屑患者的III期临床试验达到主要终点。安全性方面,莱康奇塔单抗整体安全性良好,常见不良事件发生率与对照组各类不良事件发生率相当。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385369.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01513"],"gpt_icon":0},{"id":"2594409674","title":"国产首款:丽珠医药IL-17A/F抗体申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2594409674","media":"医药笔记","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594409674?lang=zh_cn&edition=full","pubTime":"2025-12-24 11:15","pubTimestamp":1766546121,"startTime":"0","endTime":"0","summary":"▎Armstrong2025年12月24日,丽珠医药IL-17A/F抗体莱康奇塔单抗注射液的上市申请获得NMPA受理,为首款申报上市的国产IL-17A/F抗体。今年7月,丽珠医药宣布莱康奇塔单抗在银屑病三期临床中头对头击败可善挺。总结Th17通路在银屑病、银屑病关节炎、强制性脊柱炎、炎症性肠病等多个适应症表现出优异疗效。靶点角度来看,IL-17A/F、IL-23整体上表现优于IL-17A。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224115310a4718a0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224115310a4718a0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01513"],"gpt_icon":0},{"id":"2593545174","title":"每日卖空追踪 | 丽珠医药 12月22日卖空量成交1.63万股,卖空比例为5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593545174","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593545174?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:30","pubTimestamp":1766392222,"startTime":"0","endTime":"0","summary":"丽珠医药北京时间12月22日,股价较前一交易日持平,卖空量成交1.63万股,较上一交易日增加3.82%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163416a46994e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163416a46994e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01513"],"gpt_icon":0},{"id":"2593525454","title":"丽珠医药12月22日遭主力抛售27.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2593525454","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593525454?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:15","pubTimestamp":1766391338,"startTime":"0","endTime":"0","summary":"12月22日,丽珠医药股价收平报29.40元,成交金额915.4万元,换手率0.10%,振幅1.09%,量比0.47。丽珠医药今日主力资金净流出27.0万元,上一交易日主力净流出58.8万元。该股近5个交易日下跌1.34%,主力资金累计净流出323.5万元,其中3个交易日为股价上涨时净流出;近20日主力资金累计净流出435.4万元,其中净流出天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222161830a6c087a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222161830a6c087a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01513"],"gpt_icon":0},{"id":"2593312178","title":"丽珠医药(01513):NS-041 片新增治疗抑郁症适应症获得药物临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2593312178","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593312178?lang=zh_cn&edition=full","pubTime":"2025-12-21 18:33","pubTimestamp":1766313210,"startTime":"0","endTime":"0","summary":"NS-041 片是一款新型高选择性 KCNQ2/3 激动剂,目标用于癫痫和抑郁症等神经精神类疾病的治疗,系目前国内唯一获批同时开展癫痫和抑郁症临床研究的 KCNQ2/3 激动剂。2023 年 12 月 27 日,NS-041 片获批开展癫痫适应症的临床试验,目前该适应症正在进行 II 期临床研究。本次 NS-041 片新增获批的临床试验适应症为治疗抑郁症,研究表明,KCNQ2/3 通道激活剂能够调节中脑腹侧被盖区多巴胺神经元的兴奋性,从而改善相关抑郁症状。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384120.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"丽珠医药(01513):NS-041 片新增治疗抑郁症适应症获得药物临床试验批准通知书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01513"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.livzon.com.cn","stockEarnings":[{"period":"1week","weight":0.0482},{"period":"1month","weight":-0.017},{"period":"3month","weight":-0.1299},{"period":"6month","weight":0.0125},{"period":"1year","weight":0.1848},{"period":"ytd","weight":0.0526}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":0.0271},{"period":"3month","weight":-0.0022},{"period":"6month","weight":0.0867},{"period":"1year","weight":0.3633},{"period":"ytd","weight":0.0235}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"丽珠医药集团股份有限公司是一家主要从事医药产品的研发、生产及销售业务的中国公司。该公司的主要业务包括化学制剂、生物制品、原料药及中间体、中药制剂、诊断试剂和设备,以及商业发展和职能管理。该公司的主要产品品牌包括“壹丽安”(艾普拉唑肠溶片及注射用艾普拉唑钠)、“丽珠得乐”(枸橼酸铋钾)系列产品、“丽倍乐”(雷贝拉唑钠肠溶胶囊)、“维三联”(枸橼酸铋钾片/替硝唑片/克拉霉素片)、“贝依”(注射用醋酸亮丙瑞林微球)、“丽申宝”(注射用尿促卵泡素)、“乐宝得”(注射用尿促性素)、“丽福康”(注射用伏立康唑)等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.416667,"avgChangeRate":0.002946},{"month":2,"riseRate":0.583333,"avgChangeRate":0.028544},{"month":3,"riseRate":0.583333,"avgChangeRate":0.028951},{"month":4,"riseRate":0.666667,"avgChangeRate":0.03227},{"month":5,"riseRate":0.416667,"avgChangeRate":0.013787},{"month":6,"riseRate":0.5,"avgChangeRate":0.000101},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.018444},{"month":8,"riseRate":0.5,"avgChangeRate":0.000715},{"month":9,"riseRate":0.454545,"avgChangeRate":0.011936},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.019823},{"month":11,"riseRate":0.583333,"avgChangeRate":0.03425},{"month":12,"riseRate":0.5,"avgChangeRate":-0.008149}],"exchange":"SEHK","name":"丽珠医药","nameEN":"LIVZON PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"丽珠医药(01513)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供丽珠医药(01513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"丽珠医药,01513,丽珠医药股票,丽珠医药股票老虎,丽珠医药股票老虎国际,丽珠医药行情,丽珠医药股票行情,丽珠医药股价,丽珠医药股市,丽珠医药股票价格,丽珠医药股票交易,丽珠医药股票购买,丽珠医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"丽珠医药(01513)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供丽珠医药(01513)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}